Oral Oncolytics Standardization QI Project: Breast Service Line

Authors

Susan Ferguson, The University of Texas MD Anderson Cancer CenterFollow
Natalie Sanchez, The University of Texas MD Anderson Cancer CenterFollow
Tori McClosky, The University of Texas MD Anderson Cancer CenterFollow
Regina Smith, The University of Texas MD Anderson Cancer CenterFollow
Abenaa Brewster, The University of Texas MD Anderson Cancer CenterFollow

Files

Description

Oral oncolytic therapy as a breast cancer treatment allows chemo medications to be administered at home rather than by infusion within an ambulatory setting. Oral therapy has proven to be convenient, yet there are gaps within patient self-management, adherence, and education. However, the provider does not always know when the patient actually begins oral oncolytic treatment, based on when the patient’s prescription is available. Lab test and follow up results may be skewed based on variations between the order date and actual start date. Therefore, patient compliance is uncertain, causing concern for safe and effective management of oral oncolytic therapy. Additionally, there was a need to standardize the process for all breast patients seen in ambulatory areas (HAL’s & TMC). A nurse-led initiative was needed to benchmark the practices and develop a standardized operating procedure for breast cancer patients starting oral oncolytic treatment.

Category

New Program Development, Standardization of an Enterprise-wide Process

Department

Breast Medical Oncology

Recommended Citation

Ferguson, Susan; Sanchez, Natalie; McClosky, Tori; Smith, Regina; and Brewster, Abenaa, "Oral Oncolytics Standardization QI Project: Breast Service Line" (2022). Ambulatory Celebrate Improvements Fair 2023. 3.
https://openworks.mdanderson.org/acif23/3